21 completed, 17 unknown, 2 recruiting, 2 terminated. 15 Phase 4, 14 Phase 3, 9 Not applicable, 3 Phase 2.
Follow Nadroparin: new trials by email Literature Review of Nadroparin trials Research Report on Nadroparin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity Aspirin, Low-molecular-weight heparin - Venous Thromboembolism, Postpartum Period | Phase 3 | Recruiting | University of Calgary | 8805 | 2026-06-04 | 2026-07-27 |
| Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVT TIPS, Nadroparin - Portal Vein Thrombosis | Not applicable | Unknown | Shanghai Zhongshan Hospital | 84 | 2024-05-01 | 2024-03-21 |
| Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine Nadroparin Injectable Product - Aneurysmal Subarachnoid Hemorrhage, Delayed Cerebral Ischemia | Phase 2 | Recruiting | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 100 | 2022-02-02 | 2025-01-29 |
| Safety of Anticoagulant Therapy After Tissue Glue for Gastric Varices Low molecular weight heparin - Anticoagulants and Bleeding Disorders, Tissue Adhesion | Unknown | Qilu Hospital of Shandong University | 100 | 2022-01-01 | 2022-09-19 | |
| Nadroparin Pharmacokinetics in Different Stages of COVID-19 Nadroparin - Thrombosis, Nadroparin | Completed | Medical University of Lublin | 43 | 2021-02-01 | 2022-11-18 | |
| Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT） Apixaban, Warfarin, Aspirin - Cirrhosis, Splenectomy; Status | Phase 4 | Completed | Northern Jiangsu People's Hospital | 120 | 2020-11-22 | 2025-03-21 |
| Reduced Anticoagulation Targets in ECLS (RATE) Heparin, LMWH - Heart Failure, Respiratory Failure | Phase 3 | Completed | University Medical Center Groningen | 330 | 2020-10-01 | 2025-05-02 |
| Rivaroxaban for the Prevention of Deep Vein Thrombosis in Patients With Left Iliac Vein Compression - The PLICTS Study Rivaroxaban, Warfarin, Nadroparin - May-Thurner Syndrome | Phase 3 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 224 | 2020-05-18 | 2024-04-18 |
| Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 Enoxaparin - COVID, Thrombosis | Phase 4 | Completed | Central Hospital, Nancy, France | 1000 | 2020-05-13 | 2023-08-07 |
| Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters Rivaroxaban, Warfarin, Nadroparin - Venous Thromboembolism | Phase 3 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 200 | 2020-05-08 | 2024-04-18 |
| Immunosuppressant Regimens for Living Fetuses Study Prednisone, Hydroxychloroquine, Aspirin - Undifferentiated Connective Tissue Disease, Recurrent Pregnancy Loss | Not applicable | Unknown | RenJi Hospital | 420 | 2019-08-02 | 2019-08-12 |
| Anticoagulation for Advanced Cirrhotic Patients After TIPS Rivaroxaban - Liver Cirrhosis | Not applicable | Unknown | Air Force Military Medical University, China | 254 | 2017-06-14 | 2022-10-25 |
| Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosis Nadroparin calcium, warfarin - Liver Cirrhosis, Portal Vein Thrombosis | Phase 4 | Completed | Qilu Hospital of Shandong University | 64 | 2017-01-01 | 2021-03-02 |
| Leiden Trial in Prevention of Post-Operative ThromboEmbolic Events IPD Device delivered by Converis, Fraxiparine - Deep-Venous Thrombosis | Not applicable | Completed | Leiden University Medical Center | 280 | 2016-12-01 | 2025-03-10 |
| LMWH Infusion as Anticoagulation for Home HD Nadroparin, Unfractionated heparin - Endstage Renal Disease | Phase 4 | Unknown | Alice Ho Miu Ling Nethersole Hospital | 12 | 2016-03-01 | 2016-11-08 |
| The Effect of Anticoagulation in Cirrhotic Patients With Portal Vein Thrombosis：A Multicenter RCT Nadroparin Calcium and Warfarin, Doppler ultrasound and CT - Portal Vein Thrombosis, Liver Cirrhosis | Phase 4 | Unknown | Shanghai Zhongshan Hospital | 96 | 2015-12-01 | 2015-12-15 |
| Intravenous Versus Subcutaneous Administration of Low Molecular Weight Heparin for Thromboprophylaxis in Critically Ill Patients Nadroparin (intravenous Infusion), Nadroparin (subcutaneous group) - Critical Illness | Phase 4 | Completed | Clinique Saint Pierre Ottignies | 60 | 2015-04-08 | 2021-07-29 |
| The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis Nadroparin Calcium and Warfarin - Portal Vein Thrombosis, Liver Cirrhosis | Phase 4 | Unknown | Shanghai Zhongshan Hospital | 96 | 2015-03-01 | 2015-12-09 |
| Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection Warfarin, Dipyridamole, Aspirin - Cirrhosis, Hypertension | Phase 4 | Completed | Yangzhou University | 124 | 2014-09-01 | 2019-03-29 |
| Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy Warfarin, Dipyridamole, Aspirin - Cirrhosis, Hypertension | Phase 4 | Unknown | Yangzhou University | 60 | 2014-09-01 | 2019-01-02 |
Showing 20 of 43. Sign in to see all of them.
Venous Thrombosis (14) · Pulmonary Embolism (9) · Venous Thromboembolism (8) · Liver Cirrhosis (6) · Neoplasms (5) · Thrombosis (4) · Fibrosis (3) · Thromboembolism (3) · Hemorrhage (2) · Hemostatic Disorders (2) · Hypertension (2) · Lung Neoplasms (2) · Thrombophilia (2) · Acute Kidney Injury (1) · Adenocarcinoma (1)
Shanghai Zhongshan Hospital (4) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2) · Air Force Military Medical University, China (2) · Beijing Chao Yang Hospital (2) · GlaxoSmithKline (2) · Qilu Hospital of Shandong University (2) · Second Affiliated Hospital, Zhejiang University, School of Medicine (2) · Suzanne C. Cannegieter, MD PhD (2) · University Hospital, Geneva (2) · University Medical Center Groningen (2) · Yangzhou University (2) · Alice Ho Miu Ling Nethersole Hospital (1) · Central Hospital, Nancy, France (1) · Clinique Saint Pierre Ottignies (1) · Eastern Hepatobiliary Surgery Hospital (1)
China (16) · Netherlands (15) · France (7) · Canada (6) · Italy (6) · Germany (4) · Belgium (3) · Poland (3) · Russia (3) · Spain (3) · United States (3) · Austria (2) · Denmark (2) · Ireland (2) · Switzerland (2)
Dou-Sheng Bai, MD (2) · Guo-Qing Jiang, MS (2) · Ping Chen, MD (2) · Shiyao Chen, Professor (2) · Suzanne C Cannegieter, PhD, MD (2) · Bao-Huan Zhou, MS (1) · Carmen Vleggeert-Lankamp, MD MSc PhD (1) · Catherine Weber, MD (1) · Chen Wang, PhD,MD (1) · Clemens B Tempfer, MD (1) · Dou-Sheng Bai Bai, MD (1) · Egon Kurca, MD, PhD, prof (1)
PMID 27959702, PMID 33779986, PMID 38189593, PMID 10648016, PMID 12090565, PMID 16227647, PMID 16716321, PMID 17075810, PMID 1757934, PMID 18007136, PMID 18667193, PMID 19114912, PMID 19390908, PMID 19726226, PMID 20447951, PMID 20528832, PMID 22013950, PMID 22449204, PMID 22635227, PMID 22648486, PMID 23355673, PMID 24768093, PMID 24818590, PMID 24917564, PMID 25280034, PMID 25305214, PMID 25903529, PMID 26384980, PMID 26429521, PMID 27646496, PMID 27756248, PMID 27836513, PMID 28279428, PMID 30656824, PMID 31116676, PMID 31820157, PMID 32907619, PMID 32993773, PMID 33314078, PMID 33337539, PMID 33462096, PMID 33502773, PMID 34518951, PMID 34697109, PMID 35244208, PMID 35381407, PMID 35578271, PMID 36354038, PMID 36695396, PMID 37097604
2019 (1)